ServiceNow enters the week before its October earnings in an unusual position: short interest is climbing sharply while the analyst community is raising price targets at a brisk pace — two signals pointing in opposite directions.
The short side has been the more active story this week. Short interest jumped 8.6% over seven days to reach 14.4% of the free float — roughly 29.9 million shares. That follows a dramatic unwind over August, when shorts were cut nearly in half from above 26% of float in early August to a low near 13%. The current rebuild brings shorts back to roughly mid-August levels. Despite the rising short count, the borrow market remains relaxed: cost to borrow is running at just 0.43%, and availability is exceptionally loose at over 7,200% — meaning shares to lend far outnumber shares already borrowed. That rules out any mechanical squeeze pressure. The ORTEX short score has ticked steadily higher over the past two weeks, reaching 31.5, though this remains a moderate reading. The picture is one of active tactical shorting, not a crowded or distressed position.
Options positioning adds a mild layer of caution. The put/call ratio is 0.93, modestly above its 20-day average of 0.91 — about 1.2 standard deviations elevated. That's nowhere near extreme, but the drift upward is clear when compared to readings below 0.85 in late July. The 52-week range on the PCR runs from 0.60 to 1.17, so current levels sit comfortably in the middle — defensive-ish, but not alarmed. Taken alongside the short rebuild, positioning looks cautious rather than panicked.
The Street is moving the other way. Analyst activity has been bullish and recent. Needham raised its target to $155 from $115 this week, maintaining a Buy. BTIG lifted to $170 from $150 just days earlier. Those two moves alone represent substantial upward revisions against a stock trading at $132.53 — down 6.2% on the week despite a modest 1% bounce on Friday. The consensus mean target sits near $144, implying roughly 8% upside from current levels, though targets range widely: Bernstein is at $248 while Macquarie sits at $110. BofA raised to $150 in mid-August, and Wells Fargo went to $175 earlier that month. The direction of travel is unambiguously positive from the sell-side, even as the stock has given back ground this week in line with peers — CRM fell 6.3% on the week, ADBE dropped 11.7%, and MNDY lost nearly 11%, suggesting a broad sector rotation rather than a NOW-specific move.
The fundamental debate remains live. Bulls point to 9% annual contract value growth and expanding use cases in customer service and HR, with forward earnings expectations rising sharply — the 12-month forward EPS growth estimate ranks in the 61st percentile of the broader universe. Bears centre on the CRPO shortfall: contracted remaining performance obligations came in $207 million below the seasonal average last quarter, the largest sequential miss in the company's history. Federal revenue cratered 72% year-over-year. The PE multiple stands near 27.8x on reported earnings, with EV/EBITDA around 18.5x — not stretched by software standards, but not forgiving if the CRPO trend worsens. The short-score factor rank at the 73rd percentile reflects that the short-side argument has genuine traction, even with borrow conditions comfortable.
Insider activity over the past 90 days has been modestly net negative, with a net outflow of roughly $1.75 million in reported transactions. The largest single open-market sale was a $1.1 million block by the Chief People & AI Officer under a pre-arranged 10b5-1 plan — a scheduled, lower-signal transaction. Other sales were small. There is no insider buying on record. The 13D/G register carries only passive holders: BlackRock at around 8.9% and Vanguard entities collectively above 7%, with no activist on file.
With the next earnings print due October 28, the key question for the coming weeks is whether the CRPO trajectory from last quarter was a one-off reset or the start of a demand-driven deceleration — and the short rebuild this week suggests at least some investors are positioning for the latter.
See the live data behind this article on ORTEX.
Open NOW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
